These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 34768808)

  • 1. Common Pathogenic Mechanisms in Centronuclear and Myotubular Myopathies and Latest Treatment Advances.
    Gómez-Oca R; Cowling BS; Laporte J
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mice with muscle-specific deletion of Bin1 recapitulate centronuclear myopathy and acute downregulation of dynamin 2 improves their phenotypes.
    Silva-Rojas R; Nattarayan V; Jaque-Fernandez F; Gomez-Oca R; Menuet A; Reiss D; Goret M; Messaddeq N; Lionello VM; Kretz C; Cowling BS; Jacquemond V; Laporte J
    Mol Ther; 2022 Feb; 30(2):868-880. PubMed ID: 34371181
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MTM1 overexpression prevents and reverts BIN1-related centronuclear myopathy.
    Giraud Q; Spiegelhalter C; Messaddeq N; Laporte J
    Brain; 2023 Oct; 146(10):4158-4173. PubMed ID: 37490306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies.
    Toussaint A; Cowling BS; Hnia K; Mohr M; Oldfors A; Schwab Y; Yis U; Maisonobe T; Stojkovic T; Wallgren-Pettersson C; Laugel V; Echaniz-Laguna A; Mandel JL; Nishino I; Laporte J
    Acta Neuropathol; 2011 Feb; 121(2):253-66. PubMed ID: 20927630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenic mechanisms in centronuclear myopathies.
    Jungbluth H; Gautel M
    Front Aging Neurosci; 2014; 6():339. PubMed ID: 25566070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reducing dynamin 2 expression rescues X-linked centronuclear myopathy.
    Cowling BS; Chevremont T; Prokic I; Kretz C; Ferry A; Coirault C; Koutsopoulos O; Laugel V; Romero NB; Laporte J
    J Clin Invest; 2014 Mar; 124(3):1350-63. PubMed ID: 24569376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and genetic diagnosis of centronuclear myopathies in seven Chinese patients.
    Zhao Y; Zhao Z; Shen H; Bing Q; Hu J
    Neurol Sci; 2018 Dec; 39(12):2043-2051. PubMed ID: 30232666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amphiphysin 2 modulation rescues myotubular myopathy and prevents focal adhesion defects in mice.
    Lionello VM; Nicot AS; Sartori M; Kretz C; Kessler P; Buono S; Djerroud S; Messaddeq N; Koebel P; Prokic I; Hérault Y; Romero NB; Laporte J; Cowling BS
    Sci Transl Med; 2019 Mar; 11(484):. PubMed ID: 30894500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular, biochemical and molecular changes in muscles from patients with X-linked myotubular myopathy due to MTM1 mutations.
    Bachmann C; Jungbluth H; Muntoni F; Manzur AY; Zorzato F; Treves S
    Hum Mol Genet; 2017 Jan; 26(2):320-332. PubMed ID: 28007904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multi-omics comparisons of different forms of centronuclear myopathies and the effects of several therapeutic strategies.
    Djeddi S; Reiss D; Menuet A; Freismuth S; de Carvalho Neves J; Djerroud S; Massana-Muñoz X; Sosson AS; Kretz C; Raffelsberger W; Keime C; Dorchies OM; Thompson J; Laporte J
    Mol Ther; 2021 Aug; 29(8):2514-2534. PubMed ID: 33940157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Centronuclear (myotubular) myopathy.
    Jungbluth H; Wallgren-Pettersson C; Laporte J
    Orphanet J Rare Dis; 2008 Sep; 3():26. PubMed ID: 18817572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Centronuclear myopathies under attack: A plethora of therapeutic targets.
    Tasfaout H; Cowling BS; Laporte J
    J Neuromuscul Dis; 2018; 5(4):387-406. PubMed ID: 30103348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The myotubularin-amphiphysin 2 complex in membrane tubulation and centronuclear myopathies.
    Royer B; Hnia K; Gavriilidis C; Tronchère H; Tosch V; Laporte J
    EMBO Rep; 2013 Oct; 14(10):907-15. PubMed ID: 23917616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamin 2 the rescue for centronuclear myopathy.
    Demonbreun AR; McNally EM
    J Clin Invest; 2014 Mar; 124(3):976-8. PubMed ID: 24569368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of myotubularin function results in T-tubule disorganization in zebrafish and human myotubular myopathy.
    Dowling JJ; Vreede AP; Low SE; Gibbs EM; Kuwada JY; Bonnemann CG; Feldman EL
    PLoS Genet; 2009 Feb; 5(2):e1000372. PubMed ID: 19197364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult centronuclear myopathies: A hospital-based study.
    Echaniz-Laguna A; Biancalana V; Böhm J; Tranchant C; Mandel JL; Laporte J
    Rev Neurol (Paris); 2013; 169(8-9):625-31. PubMed ID: 23938035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice.
    Tasfaout H; Buono S; Guo S; Kretz C; Messaddeq N; Booten S; Greenlee S; Monia BP; Cowling BS; Laporte J
    Nat Commun; 2017 Jun; 8():15661. PubMed ID: 28589938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Necklace" fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy.
    Bevilacqua JA; Bitoun M; Biancalana V; Oldfors A; Stoltenburg G; Claeys KG; Lacène E; Brochier G; Manéré L; Laforêt P; Eymard B; Guicheney P; Fardeau M; Romero NB
    Acta Neuropathol; 2009 Mar; 117(3):283-91. PubMed ID: 19084976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. RYR1 mutations are a common cause of congenital myopathies with central nuclei.
    Wilmshurst JM; Lillis S; Zhou H; Pillay K; Henderson H; Kress W; Müller CR; Ndondo A; Cloke V; Cullup T; Bertini E; Boennemann C; Straub V; Quinlivan R; Dowling JJ; Al-Sarraj S; Treves S; Abbs S; Manzur AY; Sewry CA; Muntoni F; Jungbluth H
    Ann Neurol; 2010 Nov; 68(5):717-26. PubMed ID: 20839240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing dynamin 2 (DNM2) rescues
    Buono S; Ross JA; Tasfaout H; Levy Y; Kretz C; Tayefeh L; Matson J; Guo S; Kessler P; Monia BP; Bitoun M; Ochala J; Laporte J; Cowling BS
    Proc Natl Acad Sci U S A; 2018 Oct; 115(43):11066-11071. PubMed ID: 30291191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.